Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling.

Saved in:
Bibliographic Details
Title: Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling.
Authors: Tracey H; GSK, Stevenage SG1 2NY, UK., Bate ST; GSK, Stevenage SG1 2NY, UK., Ford S; GSK, Durham, NC 27701, USA., Patel P; ViiV Healthcare, Durham, NC 27709, USA., Bloomer J; GSK, Stevenage SG1 2NY, UK., Patel A; GSK, Stevenage SG1 2NY, UK., Taskar KS; GSK, Stevenage SG1 2NY, UK.
Source: Pharmaceutics [Pharmaceutics] 2025 Apr 18; Vol. 17 (4). Date of Electronic Publication: 2025 Apr 18.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40284525
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tracey+H%22">Tracey H</searchLink>; GSK, Stevenage SG1 2NY, UK.<br /><searchLink fieldCode="AU" term="%22Bate+ST%22">Bate ST</searchLink>; GSK, Stevenage SG1 2NY, UK.<br /><searchLink fieldCode="AU" term="%22Ford+S%22">Ford S</searchLink>; GSK, Durham, NC 27701, USA.<br /><searchLink fieldCode="AU" term="%22Patel+P%22">Patel P</searchLink>; ViiV Healthcare, Durham, NC 27709, USA.<br /><searchLink fieldCode="AU" term="%22Bloomer+J%22">Bloomer J</searchLink>; GSK, Stevenage SG1 2NY, UK.<br /><searchLink fieldCode="AU" term="%22Patel+A%22">Patel A</searchLink>; GSK, Stevenage SG1 2NY, UK.<br /><searchLink fieldCode="AU" term="%22Taskar+KS%22">Taskar KS</searchLink>; GSK, Stevenage SG1 2NY, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101534003%22">Pharmaceutics</searchLink> [Pharmaceutics] 2025 Apr 18; Vol. 17 (4). <i>Date of Electronic Publication: </i>2025 Apr 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101534003 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1999-4923 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219994923%22">19994923 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceutics <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40284525
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/pharmaceutics17040531
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tracey H
      – PersonEntity:
          Name:
            NameFull: Bate ST
      – PersonEntity:
          Name:
            NameFull: Ford S
      – PersonEntity:
          Name:
            NameFull: Patel P
      – PersonEntity:
          Name:
            NameFull: Bloomer J
      – PersonEntity:
          Name:
            NameFull: Patel A
      – PersonEntity:
          Name:
            NameFull: Taskar KS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 04
              Text: 2025 Apr 18
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1999-4923
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Pharmaceutics
              Type: main
ResultId 1